Spring Health Notches A $190 Million Series C At A $2 Billion Valuation, Making CEO April Koh The Youngest Woman To Run A Unicorn
Yale Spinout Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
Clinician and professor Amber Childs is the cofounder of Yale’s innovative GROW (Getting Racism Out of Work) Initiative